Investment
Features
FeesSafety
Academy
More
Pluang+

Compare uniQure N.V. Ordinary Shares (QURE) vs TD SYNNEX Corporation Common Stock (SNX) Price & Performance

uniQure N.V. Ordinary SharesTrade
TD SYNNEX Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

uniQure N.V. Ordinary Shares vs TD SYNNEX Corporation Common Stock — how do they compare? uniQure N.V. Ordinary Shares trades at $20.71 (market cap $1.45B), while TD SYNNEX Corporation Common Stock trades at $255 (market cap $21.04B). The key difference: TD SYNNEX Corporation Common Stock is far larger — about 14.5× uniQure N.V. Ordinary Shares's market cap, and TD SYNNEX Corporation Common Stock pays a 0.73% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and TD SYNNEX Corporation Common Stock for 0 Days on average.

QURESNX
Market Cap
$1.45B$21.04B
Volume
3,323,243641,037
Sector
HealthTechnology
52-Week High
$70.59$290.14
52-Week Low
$9.03$142.42
Typical Hold Time
0 Days0 Days
Enterprise Value
$707.46M$25.81B
Dividend Yield
—0.73%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

QURE
100% Buy0% Sell
Avg holding period · 0 Days
SNX
100% Buy0% Sell
Avg holding period · 0 Days

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →

About TD SYNNEX Corporation Common Stock

TD SYNNEX Corporation is a global IT distributor and solutions aggregator that distributes endpoint devices and data-center technologies from technology vendors to resellers and customers worldwide.

Read more on SNX →